The subcutaneous fatty tissue in specific body areasabdomen, thigh, and upper armoffers the most reliable absorption rates for semaglutide and other injectable peptides, with clinical data showing consistent pharmacokinetics when patients rotate injection sites properly
Its precisely why GLP-1 medications are being extensively studied for use cases beyond weight loss and diabetes management
The 2025 trials asked something harder: whether the drugs already on the market, at the doses and in the populations studied, can slow human neurodegeneration, and for semaglutide in Alzheimers disease and exenatide in Parkinsons disease, the answer was no
Well see the same with GLP-1. In the future, he predicts, molecules that act on the same pathways as GLP-1 may appear in foods rather than syringes
If you significantly overdosed (like injecting a week's worth instead of a day's worth), contact your healthcare provider for guidance
Can GLP-1 analogues be used for weight loss in adolescents or children